Clinical Trials Directory

Trials / Completed

CompletedNCT06095544

Enhanced Recovery After Surgery for SPK Transplantation Recipients

A Clinical Study on the Application of Enhanced Recovery After Surgery for Simultaneous Pancreas-kidney Transplantation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Second Affiliated Hospital of Guangzhou Medical University · Academic / Other
Sex
All
Age
20 Years – 62 Years
Healthy volunteers
Accepted

Summary

108 patients underwent elective SPK surgery were randomly divided into ERAS group (E) and routine care group (T). The ERAS group was consisted of evidenced-based systematic optimization approaches, while the control group received routine care.

Detailed description

Primary results: the postoperative length of stay (LoS) and hospitalization costs; second results: post-operative analgesia score (NRS) , the incidence of post-operative nausea and vomiting (PONV) , urinary catheter removal time by 7 days , post-operative gastric tube indwelling time, the incidence of ambulation within 6 days . the dosage of dobutamine using , the dosage of norepinephrine using, and the total amount of fluid and urine volume . MAP and lactate level . Peak systolic velocity (PSV) and (resistance index) RI of grafts were checked between two groups.

Conditions

Interventions

TypeNameDescription
PROCEDUREEnhanced recovery for SPK recipientsPre-operative, perioperative and post-operative were consisted of evidenced-based systematic optimization approaches.

Timeline

Start date
2021-01-01
Primary completion
2022-12-01
Completion
2023-06-01
First posted
2023-10-23
Last updated
2023-10-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06095544. Inclusion in this directory is not an endorsement.